Letrozole

FDA approves lapatinib with letrozole for advanced breast cancer.

Monday, February 1st, 2010

MedPage Today (1/31, Fiore) reported, “The FDA has approved a combination of lapatinib (Tykerb) and letrozole (Femara) to treat hormone-positive and HER2-positive advanced breast cancer in postmenopausal women.” The approval was based on “a company-sponsored study that found that women with HER2-positive disease who were taking the combination had survival [...]

Cognitive Function Is Superior In Breast Cancer Patients Treated With Letrozole Versus Tamoxifen

Friday, July 17th, 2009

Source: Medical News Today
New results show that postmenopausal women with breast cancer receiving adjuvant letrozole have better cognitive function than women being treated with tamoxifen. The data, from a recent meeting of the American Society of Clinical Oncology (ASCO), are drawn from a sub-study of the Breast International Group (BIG) 1-98 trial.
The trial, which enrolled [...]